PHARMACIA AND UPJOHN
Big PharmaPHARMACIA AND UPJOHN is a major pharmaceutical company focused on Dermatology, Infectious Disease, Respiratory.
PHARMACIA AND UPJOHN's Key Drugs
PHARMACIA AND UPJOHN's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PHARMACIA AND UPJOHN's Recent FDA Approvals
New NDA/BLA approvals for PHARMACIA AND UPJOHN over the last two years — novel drugs only, excluding generics and label supplements.
PHARMACIA AND UPJOHN's Therapeutic Areas
PHARMACIA AND UPJOHN's approved drugs and pipeline span 5 therapeutic areas, led by Dermatology and Infectious Disease, across 0 biologic and 6 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PHARMACIA AND UPJOHN's Top Competitors
PHARMACIA AND UPJOHN's closest competitors by therapeutic-area and drug-target overlap include GSK, Pfizer, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PHARMACIA AND UPJOHN Pipeline Snapshot
Active clinical trials for PHARMACIA AND UPJOHN across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1942-02-05
- Latest
- 2025-11-04
- Applications
- 72